BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

852 related articles for article (PubMed ID: 31752906)

  • 21. LINC01133 as ceRNA inhibits gastric cancer progression by sponging miR-106a-3p to regulate APC expression and the Wnt/β-catenin pathway.
    Yang XZ; Cheng TT; He QJ; Lei ZY; Chi J; Tang Z; Liao QX; Zhang H; Zeng LS; Cui SZ
    Mol Cancer; 2018 Aug; 17(1):126. PubMed ID: 30134915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. lncRNA OIP5-AS1 Suppresses Cell Proliferation and Invasion of Endometrial Cancer by Regulating PTEN/AKT via Sponging miR-200c-3p.
    Liu Y; Cai X; Cai Y; Chang Y
    J Immunol Res; 2021; 2021():4861749. PubMed ID: 34368370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RUNX1-activated upregulation of lncRNA RNCR3 promotes cell proliferation, invasion, and suppresses apoptosis in colorectal cancer via miR-1301-3p/AKT1 axis in vitro and in vivo.
    Xu G; Wang H; Yuan D; Yao J; Meng L; Li K; Zhang Y; Dang C; Zhu K
    Clin Transl Oncol; 2020 Oct; 22(10):1762-1777. PubMed ID: 32239427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long non-coding RNA TTN-AS1 facilitates tumorigenesis of papillary thyroid cancer through modulating the miR-153-3p/ZNRF2 axis.
    Cui Z; Luo Z; Lin Z; Shi L; Hong Y; Yan C
    J Gene Med; 2019 May; 21(5):e3083. PubMed ID: 30811764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway.
    Li C; Feng S; Chen L
    Mol Cell Biochem; 2021 Feb; 476(2):699-713. PubMed ID: 33106913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LncRNA TTN-AS1 acts as a tumor promoter in gallbladder carcinoma by regulating miR-107/HMGA1 axis.
    Lin Z; Li Y; Shao R; Hu Y; Gao H
    World J Surg Oncol; 2021 Jun; 19(1):163. PubMed ID: 34090483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long non-coding RNA MINCR promotes gallbladder cancer progression through stimulating EZH2 expression.
    Wang SH; Yang Y; Wu XC; Zhang MD; Weng MZ; Zhou D; Wang JD; Quan ZW
    Cancer Lett; 2016 Sep; 380(1):122-33. PubMed ID: 27345740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long Non-Coding RNA AC008972.1 as a Novel Therapeutic Target for Prostate Cancer.
    Zeng Q; Liu J; Wu Q; Song R; Miao W; Ma Y; Yang H
    Cancer Biother Radiopharm; 2024 May; 39(4):291-305. PubMed ID: 36094409
    [No Abstract]   [Full Text] [Related]  

  • 29. miR-324-5p inhibits gallbladder carcinoma cell metastatic behaviours by downregulation of transforming growth factor beta 2 expression.
    Zhang X; Zhang L; Chen M; Liu D
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):315-324. PubMed ID: 31858815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular mechanism of miR-34b-5p and RNA binding protein HuR binding to lncRNA OIP5-AS1 in colon cancer cells.
    Wang Y; Lin C; Liu Y
    Cancer Gene Ther; 2022 May; 29(5):612-624. PubMed ID: 34021273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CircHERC1 promotes non-small cell lung cancer cell progression by sequestering FOXO1 in the cytoplasm and regulating the miR-142-3p-HMGB1 axis.
    Cui Y; Wu X; Jin J; Man W; Li J; Li X; Li Y; Yao H; Zhong R; Chen S; Wu J; Zhu T; Lin Y; Xu J; Wang Y
    Mol Cancer; 2023 Nov; 22(1):179. PubMed ID: 37932766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acylcarnitines promote gallbladder cancer metastasis through lncBCL2L11-THOC5-JNK axis.
    Yang Y; Li H; Liu K; Zou L; Xiang S; Geng Y; Li X; Qiu S; Yang J; Cui X; Li L; Li Y; Li W; Yan S; Liu L; Wu X; Liu F; Wu W; Chen S; Liu Y
    J Transl Med; 2024 Mar; 22(1):299. PubMed ID: 38519939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long non-coding RNA Malat1 promotes gallbladder cancer development by acting as a molecular sponge to regulate miR-206.
    Wang SH; Zhang WJ; Wu XC; Zhang MD; Weng MZ; Zhou D; Wang JD; Quan ZW
    Oncotarget; 2016 Jun; 7(25):37857-37867. PubMed ID: 27191262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LncRNA TUG1 regulates the balance of HuR and miR-29b-3p and inhibits intestinal epithelial cell apoptosis in a mouse model of ulcerative colitis.
    Tian Y; Wang Y; Li F; Yang J; Xu Y; Ouyang M
    Hum Cell; 2021 Jan; 34(1):37-48. PubMed ID: 33047284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long non-coding RNA SPRY4-IT1 promotes gallbladder carcinoma progression.
    Yang L; Cheng X; Ge N; Guo W; Feng F; Wan F
    Oncotarget; 2017 Jan; 8(2):3104-3110. PubMed ID: 27902971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-143-3p targeting of ITGA6 suppresses tumour growth and angiogenesis by downregulating PLGF expression via the PI3K/AKT pathway in gallbladder carcinoma.
    Jin YP; Hu YP; Wu XS; Wu YS; Ye YY; Li HF; Liu YC; Jiang L; Liu FT; Zhang YJ; Hao YJ; Liu XY; Liu YB
    Cell Death Dis; 2018 Feb; 9(2):182. PubMed ID: 29416013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. STAT3-induced upregulation of lncRNA ABHD11-AS1 promotes tumour progression in papillary thyroid carcinoma by regulating miR-1301-3p/STAT3 axis and PI3K/AKT signalling pathway.
    Wen J; Wang H; Dong T; Gan P; Fang H; Wu S; Li J; Zhang Y; Du R; Zhu Q
    Cell Prolif; 2019 Mar; 52(2):e12569. PubMed ID: 30657221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional Role of a Novel Long Noncoding RNA
    Lin C; Zhang S; Wang Y; Wang Y; Nice E; Guo C; Zhang E; Yu L; Li M; Liu C; Hu L; Hao J; Qi W; Xu H
    Clin Cancer Res; 2018 Jan; 24(2):486-498. PubMed ID: 29101304
    [No Abstract]   [Full Text] [Related]  

  • 39. LncRNA FGD5-AS1/miR-5590-3p axis facilitates the proliferation and metastasis of renal cell carcinoma through ERK/AKT signalling.
    Yang Y; Dong MH; Hu HM; Min QH; Xiao L
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8756-8766. PubMed ID: 32964964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long noncoding RNA MALAT1 potentiates growth and inhibits senescence by antagonizing ABI3BP in gallbladder cancer cells.
    Lin N; Yao Z; Xu M; Chen J; Lu Y; Yuan L; Zhou S; Zou X; Xu R
    J Exp Clin Cancer Res; 2019 Jun; 38(1):244. PubMed ID: 31174563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.